Multiomics Profiling Reveals Signatures of Dysmetabolism in Urban Populations in Central India.
diabetes mellitus
dysmetabolism
geography
glycome
host–microbe interactions
multiomics
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
12 Jul 2021
12 Jul 2021
Historique:
received:
08
05
2021
revised:
27
06
2021
accepted:
07
07
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
8
8
2021
Statut:
epublish
Résumé
Non-communicable diseases (NCDs) have become a major cause of morbidity and mortality in India. Perturbation of host-microbiome interactions may be a key mechanism by which lifestyle-related risk factors such as tobacco use, alcohol consumption, and physical inactivity may influence metabolic health. There is an urgent need to identify relevant dysmetabolic traits for predicting risk of metabolic disorders, such as diabetes, among susceptible Asian Indians where NCDs are a growing epidemic. Here, we report the first in-depth phenotypic study in which we prospectively enrolled 218 adults from urban and rural areas of Central India and used multiomic profiling to identify relationships between microbial taxa and circulating biomarkers of cardiometabolic risk. Assays included fecal microbiota analysis by 16S ribosomal RNA gene amplicon sequencing, quantification of serum short chain fatty acids by gas chromatography-mass spectrometry, and multiplex assaying of serum diabetic proteins, cytokines, chemokines, and multi-isotype antibodies. Sera was also analysed for Multiple hallmarks of dysmetabolism were identified in urbanites and young overweight adults, the majority of whom did not have a known diagnosis of diabetes. Association analyses revealed several host-microbe and metabolic associations. Host-microbe and metabolic interactions are differentially shaped by body weight and geographic status in Central Indians. Further exploration of these links may help create a molecular-level map for estimating risk of developing metabolic disorders and designing early interventions.
Sections du résumé
BACKGROUND
BACKGROUND
Non-communicable diseases (NCDs) have become a major cause of morbidity and mortality in India. Perturbation of host-microbiome interactions may be a key mechanism by which lifestyle-related risk factors such as tobacco use, alcohol consumption, and physical inactivity may influence metabolic health. There is an urgent need to identify relevant dysmetabolic traits for predicting risk of metabolic disorders, such as diabetes, among susceptible Asian Indians where NCDs are a growing epidemic.
METHODS
METHODS
Here, we report the first in-depth phenotypic study in which we prospectively enrolled 218 adults from urban and rural areas of Central India and used multiomic profiling to identify relationships between microbial taxa and circulating biomarkers of cardiometabolic risk. Assays included fecal microbiota analysis by 16S ribosomal RNA gene amplicon sequencing, quantification of serum short chain fatty acids by gas chromatography-mass spectrometry, and multiplex assaying of serum diabetic proteins, cytokines, chemokines, and multi-isotype antibodies. Sera was also analysed for
RESULTS
RESULTS
Multiple hallmarks of dysmetabolism were identified in urbanites and young overweight adults, the majority of whom did not have a known diagnosis of diabetes. Association analyses revealed several host-microbe and metabolic associations.
CONCLUSIONS
CONCLUSIONS
Host-microbe and metabolic interactions are differentially shaped by body weight and geographic status in Central Indians. Further exploration of these links may help create a molecular-level map for estimating risk of developing metabolic disorders and designing early interventions.
Identifiants
pubmed: 34361920
pii: microorganisms9071485
doi: 10.3390/microorganisms9071485
pmc: PMC8307859
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIHR Nottingham Digestive Diseases Biomedical Research Centre
ID : NA
Organisme : University of Nottingham
ID : Anne McLaren Fellowship
Organisme : Nottingham Trent University
ID : Quality Research Funds
Organisme : NIDDK NIH HHS
ID : K01 DK111794
Pays : United States
Organisme : NIHR Surgical Reconstruction Microbiology Research Centre
ID : NA
Organisme : Crohn's and Colitis Foundation
ID : Litwin initiative
Organisme : European Structural and Investment Funds
ID : KK.01.2.2.03.0006
Organisme : Croatian National Centre of Research Excellence in Personalized Healthcare
ID : KK.01.1.1.01.0010
Références
Nat Commun. 2015 Mar 25;6:6505
pubmed: 25807110
Methods Mol Biol. 2017;1503:13-19
pubmed: 27743355
Biochemistry (Mosc). 2015 Jul;80(7):934-42
pubmed: 26542006
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Front Immunol. 2012 Apr 04;3:66
pubmed: 22566947
Diabetologia. 2001 Sep;44(9):1094-101
pubmed: 11596662
Biochim Biophys Acta. 2016 Aug;1860(8):1574-82
pubmed: 26500099
Nature. 2015 Feb 26;518(7540):S14-5
pubmed: 25715276
Lancet Glob Health. 2018 Dec;6(12):e1352-e1362
pubmed: 30219315
Sci Data. 2019 Dec 19;6(1):328
pubmed: 31857590
Methods. 2018 Oct 1;149:49-58
pubmed: 29704662
Diabetol Metab Syndr. 2014 Apr 03;6(1):50
pubmed: 24694251
Diabetologia. 2017 Dec;60(12):2352-2360
pubmed: 28905229
Front Microbiol. 2017 Jun 30;8:1226
pubmed: 28713353
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Cell Immunol. 2018 Nov;333:65-79
pubmed: 30107893
PLoS One. 2020 Oct 19;15(10):e0240971
pubmed: 33075086
Diabetes Metab Syndr Obes. 2014 Dec 04;7:587-91
pubmed: 25506234
FEBS Lett. 2019 Jul;593(13):1598-1615
pubmed: 31215021
Curr Obes Rep. 2019 Sep;8(3):317-332
pubmed: 31175629
FEBS Lett. 2019 Nov;593(21):2966-2976
pubmed: 31509238
Appl Environ Microbiol. 2011 May;77(10):3219-26
pubmed: 21421784
Gut. 2021 Jan;70(1):92-105
pubmed: 33106354
Endocr Pract. 2016 Oct;22(10):1224-1234
pubmed: 27409822
J Clin Immunol. 2014 Jul;34 Suppl 1:S12-21
pubmed: 24691998
Int J Mol Sci. 2019 May 18;20(10):
pubmed: 31109071
Cell Host Microbe. 2016 Aug 10;20(2):202-14
pubmed: 27476413
EBioMedicine. 2020 Jan;51:102590
pubmed: 31901868
Immunogenetics. 1994;39(3):187-93
pubmed: 8276465
Gastroenterology. 2019 Dec;157(6):1676-1678.e3
pubmed: 31476300
J Transl Med. 2019 May 14;17(1):155
pubmed: 31088492
J Glob Health. 2014 Jun;4(1):010404
pubmed: 24976963
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Gut Microbes. 2020 Nov 9;12(1):1752605
pubmed: 32459982
Diabetes Care. 2016 May;39(5):833-46
pubmed: 27208380
Lancet. 2017 Dec 2;390(10111):2437-2460
pubmed: 29150201
J Neurosurg. 2019 Nov 22;:1-8
pubmed: 31756713
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596
pubmed: 28601585
Lancet Glob Health. 2018 Dec;6(12):e1262-e1263
pubmed: 30292427
Am J Clin Nutr. 2013 Jul;98(1):111-20
pubmed: 23719549
Front Immunol. 2019 Mar 11;10:277
pubmed: 30915065
Front Endocrinol (Lausanne). 2019 Sep 27;10:649
pubmed: 31611845
Gastroenterology. 2018 Apr;154(5):1320-1333.e10
pubmed: 29309774
J Family Med Prim Care. 2019 Feb;8(2):326-329
pubmed: 30984632
Nature. 2019 May;569(7758):663-671
pubmed: 31142858
Science. 2018 Mar 23;359(6382):1376-1383
pubmed: 29519916
J Clin Endocrinol Metab. 2011 Jun;96(6):1654-63
pubmed: 21602457
J Diabetes Res. 2019 Apr 4;2019:2310235
pubmed: 31089471
Curr Protoc Bioinformatics. 2019 Dec;68(1):e86
pubmed: 31756036
Diabetes Res Clin Pract. 2015 Nov;110(2):172-82
pubmed: 26432412
J Clin Invest. 2011 Jun;121(6):2111-7
pubmed: 21633179
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 5;784(2):395-403
pubmed: 12505787